Global Polyethersulfone Hemodialyzer Market Growth 2026-2032

October 2026 | 97 pages | ID: GB5D33B1B248EN
LP Information

US$ 3,660.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Polyethersulfone Hemodialyzer market size is predicted to grow from US$ 871 million in 2025 to US$ 1355 million in 2032; it is expected to grow at a CAGR of 7.0% from 2026 to 2032.

Polyethersulfone Hemodialyzer is a disposable extracorporeal blood purification device that uses polyethersulfone (PES) hollow-fiber membranes as the core separation medium for hemodialysis and related renal replacement therapies. During treatment, blood flows through the lumen of thousands of hollow fibers while dialysis fluid passes outside the fibers in the opposite direction, allowing uremic toxins, excess electrolytes and water to cross the semipermeable membrane through diffusion and ultrafiltration while retaining blood cells and most essential macromolecules. The performance of Polyethersulfone Hemodialyzer is primarily determined by membrane pore structure, effective membrane area, ultrafiltration coefficient, solute clearance, hydraulic permeability, blood compatibility, endotoxin retention and sterilization stability. Commercial products are commonly differentiated by permeability level, membrane surface area, sterilization method and intended treatment mode, with applications centered on conventional hemodialysis, high-flux hemodialysis and, for appropriately designed products, hemodiafiltration. The research scope focuses on finished hemodialyzers whose functional membrane is based on polyethersulfone hollow fibers and evaluates the market from product technology, treatment application, regional demand, supply chain and competitive-structure perspectives.

Key Findings

Polyethersulfone hollow-fiber membranes have become one of the mainstream synthetic membrane platforms used in modern hemodialysis

High-flux Polyethersulfone Hemodialyzer is gaining importance as dialysis centers pursue higher middle-molecule clearance

Membrane formulation, hollow-fiber spinning consistency and sterilization stability are key determinants of product performance and manufacturing competitiveness

Demand is closely linked to dialysis patient growth, treatment penetration and expansion of professional dialysis centers

Asia-Pacific represents an increasingly important production and consumption base for Polyethersulfone Hemodialyzer

Market Trends

The Polyethersulfone Hemodialyzer industry is moving toward higher permeability, better biocompatibility, more consistent pore-size control and improved compatibility with high-efficiency dialysis modalities. Product development increasingly emphasizes higher clearance of middle-molecular-weight toxins while maintaining adequate albumin retention, stable ultrafiltration performance and low blood-cell activation. High-flux products are becoming more prominent in clinical practice, while manufacturers are optimizing membrane surface treatment, hydrophilicity and internal fiber geometry to reduce protein adsorption and improve hemocompatibility. At the manufacturing level, automated hollow-fiber spinning, online membrane inspection, more precise potting and assembly, and tighter sterilization validation are raising product consistency. Another long-term trend is closer integration between dialyzers, dialysis machines and hemodiafiltration protocols, which is encouraging the development of products with lower priming volume, better hydraulic performance and more standardized operating characteristics.

Market Dynamics

Drivers

The principal drivers of the Polyethersulfone Hemodialyzer market are the continuing increase in patients requiring renal replacement therapy, expansion of dialysis infrastructure and the gradual improvement of treatment accessibility in emerging healthcare markets. Demand is also supported by the clinical transition toward high-flux dialysis and more intensive toxin-removal strategies, which increase requirements for membrane permeability, clearance efficiency and treatment reliability. Expansion of independent dialysis centers, hospital nephrology departments and public reimbursement programs further enlarges the installed treatment base and generates recurring demand because dialyzers are generally single-use consumables in many markets.

Restraints

Market expansion is constrained by strong purchasing-price pressure, strict medical-device regulation and the technically demanding nature of hollow-fiber membrane manufacturing. Polyethersulfone resin is only one part of the cost structure; manufacturers must also control pore-forming additives, solvents, spinning conditions, washing, drying, potting, housing assembly and sterilization with high consistency. Small variations in membrane morphology can affect clearance, ultrafiltration and blood compatibility, creating substantial requirements for process validation and quality control. Competitive tendering by hospitals and dialysis chains can additionally compress margins, particularly for standardized dialyzer specifications.

Opportunities

Future opportunities are concentrated in high-flux dialysis, hemodiafiltration-compatible products, emerging-market dialysis expansion and differentiated membrane technologies. As healthcare systems increasingly focus on treatment quality and long-term outcomes, dialyzers capable of achieving efficient middle-molecule removal with stable albumin retention may obtain greater clinical attention. Manufacturers also have opportunities to develop lower-priming-volume configurations, expanded membrane-area ranges and treatment-specific products for different patient profiles. Localization of manufacturing in markets with rapidly expanding dialysis capacity can further improve supply security, shorten delivery cycles and strengthen participation in public procurement.

Challenges

The industry faces long-term challenges related to maintaining membrane consistency at large production scale, controlling manufacturing costs and satisfying increasingly stringent regulatory and clinical-performance requirements. Product recalls or deviations in fiber integrity, sterilization, endotoxin control or blood compatibility can have significant commercial consequences. At the same time, manufacturers must balance higher permeability and toxin clearance against albumin loss and other safety considerations. Intense price competition, hospital tenders, regional reimbursement differences and the need to obtain separate regulatory approvals across major markets also increase commercialization complexity.

Industry Chain Analysis

The upstream chain of Polyethersulfone Hemodialyzer centers on medical-grade polyethersulfone resin, hydrophilic modifiers such as polyvinylpyrrolidone, membrane-processing solvents, polyurethane potting materials, polymer housings, sealing components and sterilization-related materials. Among these inputs, membrane-grade PES resin, pore-forming additives and high-purity process chemicals have the greatest influence on membrane structure and filtration performance. Stable raw-material purity and batch consistency are essential because changes in polymer molecular characteristics, additive ratios or solvent quality can alter pore size, wall thickness and hydraulic permeability.

The midstream stage creates the largest amount of technical value through polymer formulation, hollow-fiber spinning, coagulation, washing, drying, fiber bundling, potting, cutting, housing assembly, sterilization and final performance testing. Key manufacturing capabilities include control of inner diameter, wall thickness, pore distribution, membrane surface properties, effective area and fiber integrity. Downstream demand comes primarily from hospital nephrology departments, dialysis centers, dialysis service networks and medical-device distributors. Profitability is therefore determined not only by raw-material cost but also by membrane technology, production yield, automation, regulatory compliance, quality consistency, manufacturing scale and access to dialysis procurement channels.

Segment Insights

From a performance perspective, Polyethersulfone Hemodialyzer can broadly be divided into low-flux and high-flux products, with additional differentiation by membrane area, ultrafiltration characteristics and sterilization method. High-flux products are becoming increasingly important because they provide greater permeability and more effective removal of selected middle-molecular-weight toxins and can support more intensive dialysis strategies. Their adoption is particularly strong in markets where high-flux hemodialysis and hemodiafiltration are well established. Low-flux products continue to serve conventional treatment requirements and remain relevant in price-sensitive healthcare systems where procurement cost and basic dialysis availability are key considerations.

Product differentiation is also shifting from simple membrane-area expansion toward a more balanced combination of clearance, ultrafiltration coefficient, albumin retention, priming volume and blood compatibility. Larger membrane-area configurations are generally used where higher clearance is required, while smaller configurations address patients with lower treatment requirements or specific clinical conditions. This creates room for manufacturers to develop broader product portfolios rather than relying on a single standardized specification.

Downstream Market Opportunities

The main downstream opportunities for Polyethersulfone Hemodialyzer are associated with the continuing expansion and modernization of dialysis treatment networks. Large dialysis centers increasingly value products that combine stable clearance, predictable ultrafiltration, low complication risk and compatibility with standardized treatment protocols, while hospitals require wider specification ranges to accommodate different patient profiles. The development of high-flux dialysis and hemodiafiltration creates additional opportunities for higher-performance dialyzers, and emerging healthcare markets offer structural growth potential as dialysis capacity, insurance coverage and treatment frequency improve. Manufacturers that can combine clinical performance with reliable supply, competitive lifecycle cost and broad machine compatibility are better positioned to capture these downstream opportunities.

Regional Insights

North America, Europe and Japan are mature markets characterized by high dialysis penetration, established treatment protocols and strong adoption of synthetic high-flux membranes. Demand in these regions is increasingly driven by product replacement, clinical-performance improvement and the transition toward higher-efficiency dialysis rather than basic capacity expansion. Europe is particularly relevant to the development of high-flux dialysis and hemodiafiltration, creating sustained demand for dialyzers with high permeability and tightly controlled membrane performance.

Asia-Pacific is becoming increasingly important to both production and consumption. China combines a large dialysis patient population with expanding domestic dialyzer manufacturing capacity, while other Asian markets continue to invest in dialysis infrastructure and treatment accessibility. Emerging regions in Latin America, the Middle East, Africa and parts of Southeast Asia also offer longer-term opportunities, although procurement budgets, reimbursement systems, local registration requirements and treatment availability create significant differences in product mix and pricing between countries.

Competitive Landscape Analysis

The Polyethersulfone Hemodialyzer market is characterized by competition between vertically integrated global dialysis companies, specialized dialyzer manufacturers and regional medical-device producers. Competitive advantages are built primarily around membrane formulation, hollow-fiber spinning technology, high production yield, product consistency, clinical performance, regulatory certifications and access to hospital or dialysis-center procurement networks. Established manufacturers benefit from accumulated membrane-process know-how and the ability to integrate dialyzers with dialysis machines and broader renal-care portfolios, while regional suppliers often compete through localized manufacturing, responsive supply and pricing advantages. As basic product specifications become increasingly standardized, differentiation is shifting toward high-flux performance, middle-molecule clearance, blood compatibility, sterilization technology, manufacturing quality and the ability to provide a complete portfolio covering different membrane areas and treatment modalities.

Report Scope

LP Information, Inc. (LPI) ' newest research report, the “Polyethersulfone Hemodialyzer Industry Forecast” looks at past sales and reviews total world Polyethersulfone Hemodialyzer sales in 2025, providing a comprehensive analysis by region and market sector of projected Polyethersulfone Hemodialyzer sales for 2026 through 2032. With Polyethersulfone Hemodialyzer sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Polyethersulfone Hemodialyzer industry.

This Insight Report provides a comprehensive analysis of the global Polyethersulfone Hemodialyzer landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Polyethersulfone Hemodialyzer portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Polyethersulfone Hemodialyzer market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Polyethersulfone Hemodialyzer and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Polyethersulfone Hemodialyzer.

This report presents a comprehensive overview, market shares, and growth opportunities of Polyethersulfone Hemodialyzer market by product type, application, key manufacturers and key regions and countries.

Market Segmentation

Segmentation by Type:

  • Low-Flux
  • High-Flux

Segmentation by Ultrafiltration Coefficient:

  • Low-KUF Dialyzer
  • High-KUF Dialyzer

Segmentation by Membrane Structure:

  • Conventional PES Membrane Hemodialyzer
  • PES/PVP Modified Membrane Hemodialyzer

Segmentation by Application:

  • Hospital
  • Dialysis Center
  • Other

This report also splits the market by region:

  • Americas
    • United States
    • Canada
    • Mexico
    • Brazil
  • APAC
    • China
    • Japan
    • Korea
    • Southeast Asia
    • India
    • Australia
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Russia
  • Middle East & Africa
    • Egypt
    • South Africa
    • Israel
    • Turkey
    • GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
  • Nipro
  • JMS
  • Farmasol
  • Mozarc
  • Bain Medical
  • Jiangxi Sanxin Medtec
  • SWS Hemodialysis Care
  • Shanghai Peony Medical
  • OCI Medical Device
  • Guangdong Baihe Medical

Key Questions Addressed in this Report

  • What is the 10-year outlook for the global Polyethersulfone Hemodialyzer market?
  • What factors are driving Polyethersulfone Hemodialyzer market growth, globally and by region?
  • Which technologies are poised for the fastest growth by market and region?
  • How do Polyethersulfone Hemodialyzer market opportunities vary by end market size?
  • How does Polyethersulfone Hemodialyzer break out by Type, by Application?
1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Polyethersulfone Hemodialyzer Annual Sales 2021-2032
  2.1.2 World Current & Future Analysis for Polyethersulfone Hemodialyzer by Geographic Region, 2021, 2025 & 2032
  2.1.3 World Current & Future Analysis for Polyethersulfone Hemodialyzer by Country/Region, 2021, 2025 & 2032
2.2 Polyethersulfone Hemodialyzer Segment by Type
  2.2.1 Low-Flux
  2.2.2 High-Flux
  2.2.3 Polyethersulfone Hemodialyzer Sales by Type
    2.2.3.1 Global Polyethersulfone Hemodialyzer Sales Market Share by Type (2021-2026)
    2.2.3.2 Global Polyethersulfone Hemodialyzer Revenue and Market Share by Type (2021-2026)
    2.2.3.3 Global Polyethersulfone Hemodialyzer Sale Price by Type (2021-2026)
2.3 Polyethersulfone Hemodialyzer Segment by Ultrafiltration Coefficient
  2.3.1 Low-KUF Dialyzer
  2.3.2 High-KUF Dialyzer
  2.3.3 Polyethersulfone Hemodialyzer Sales by Ultrafiltration Coefficient
    2.3.3.1 Global Polyethersulfone Hemodialyzer Sales Market Share by Ultrafiltration Coefficient (2021-2026)
    2.3.3.2 Global Polyethersulfone Hemodialyzer Revenue and Market Share by Ultrafiltration Coefficient (2021-2026)
    2.3.3.3 Global Polyethersulfone Hemodialyzer Sale Price by Ultrafiltration Coefficient (2021-2026)
2.4 Polyethersulfone Hemodialyzer Segment by Membrane Structure
  2.4.1 Conventional PES Membrane Hemodialyzer
  2.4.2 PES/PVP Modified Membrane Hemodialyzer
  2.4.3 Polyethersulfone Hemodialyzer Sales by Membrane Structure
    2.4.3.1 Global Polyethersulfone Hemodialyzer Sales Market Share by Membrane Structure (2021-2026)
    2.4.3.2 Global Polyethersulfone Hemodialyzer Revenue and Market Share by Membrane Structure (2021-2026)
    2.4.3.3 Global Polyethersulfone Hemodialyzer Sale Price by Membrane Structure (2021-2026)
2.5 Polyethersulfone Hemodialyzer Segment by Application
  2.5.1 Hospital
  2.5.2 Dialysis Center
  2.5.3 Other
  2.5.4 Polyethersulfone Hemodialyzer Sales by Application
    2.5.4.1 Global Polyethersulfone Hemodialyzer Sale Market Share by Application (2021-2026)
    2.5.4.2 Global Polyethersulfone Hemodialyzer Revenue and Market Share by Application (2021-2026)
    2.5.4.3 Global Polyethersulfone Hemodialyzer Sale Price by Application (2021-2026)

3 GLOBAL BY COMPANY

3.1 Global Polyethersulfone Hemodialyzer Breakdown Data by Company
  3.1.1 Global Polyethersulfone Hemodialyzer Annual Sales by Company (2021-2026)
  3.1.2 Global Polyethersulfone Hemodialyzer Sales Market Share by Company (2021-2026)
3.2 Global Polyethersulfone Hemodialyzer Annual Revenue by Company (2021-2026)
  3.2.1 Global Polyethersulfone Hemodialyzer Revenue by Company (2021-2026)
  3.2.2 Global Polyethersulfone Hemodialyzer Revenue Market Share by Company (2021-2026)
3.3 Global Polyethersulfone Hemodialyzer Sale Price by Company
3.4 Key Manufacturers Polyethersulfone Hemodialyzer Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Polyethersulfone Hemodialyzer Product Location Distribution
  3.4.2 Players Polyethersulfone Hemodialyzer Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy

4 WORLD HISTORIC REVIEW FOR POLYETHERSULFONE HEMODIALYZER BY GEOGRAPHIC REGION

4.1 World Historic Polyethersulfone Hemodialyzer Market Size by Geographic Region (2021-2026)
  4.1.1 Global Polyethersulfone Hemodialyzer Annual Sales by Geographic Region (2021-2026)
  4.1.2 Global Polyethersulfone Hemodialyzer Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Polyethersulfone Hemodialyzer Market Size by Country/Region (2021-2026)
  4.2.1 Global Polyethersulfone Hemodialyzer Annual Sales by Country/Region (2021-2026)
  4.2.2 Global Polyethersulfone Hemodialyzer Annual Revenue by Country/Region (2021-2026)
4.3 Americas Polyethersulfone Hemodialyzer Sales Growth
4.4 APAC Polyethersulfone Hemodialyzer Sales Growth
4.5 Europe Polyethersulfone Hemodialyzer Sales Growth
4.6 Middle East & Africa Polyethersulfone Hemodialyzer Sales Growth

5 AMERICAS

5.1 Americas Polyethersulfone Hemodialyzer Sales by Country
  5.1.1 Americas Polyethersulfone Hemodialyzer Sales by Country (2021-2026)
  5.1.2 Americas Polyethersulfone Hemodialyzer Revenue by Country (2021-2026)
5.2 Americas Polyethersulfone Hemodialyzer Sales by Type (2021-2026)
5.3 Americas Polyethersulfone Hemodialyzer Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Polyethersulfone Hemodialyzer Sales by Region
  6.1.1 APAC Polyethersulfone Hemodialyzer Sales by Region (2021-2026)
  6.1.2 APAC Polyethersulfone Hemodialyzer Revenue by Region (2021-2026)
6.2 APAC Polyethersulfone Hemodialyzer Sales by Type (2021-2026)
6.3 APAC Polyethersulfone Hemodialyzer Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Polyethersulfone Hemodialyzer by Country
  7.1.1 Europe Polyethersulfone Hemodialyzer Sales by Country (2021-2026)
  7.1.2 Europe Polyethersulfone Hemodialyzer Revenue by Country (2021-2026)
7.2 Europe Polyethersulfone Hemodialyzer Sales by Type (2021-2026)
7.3 Europe Polyethersulfone Hemodialyzer Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Polyethersulfone Hemodialyzer by Country
  8.1.1 Middle East & Africa Polyethersulfone Hemodialyzer Sales by Country (2021-2026)
  8.1.2 Middle East & Africa Polyethersulfone Hemodialyzer Revenue by Country (2021-2026)
8.2 Middle East & Africa Polyethersulfone Hemodialyzer Sales by Type (2021-2026)
8.3 Middle East & Africa Polyethersulfone Hemodialyzer Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Polyethersulfone Hemodialyzer
10.3 Manufacturing Process Analysis of Polyethersulfone Hemodialyzer
10.4 Industry Chain Structure of Polyethersulfone Hemodialyzer

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Polyethersulfone Hemodialyzer Distributors
11.3 Polyethersulfone Hemodialyzer Customer

12 WORLD FORECAST REVIEW FOR POLYETHERSULFONE HEMODIALYZER BY GEOGRAPHIC REGION

12.1 Global Polyethersulfone Hemodialyzer Market Size Forecast by Region
  12.1.1 Global Polyethersulfone Hemodialyzer Forecast by Region (2027-2032)
  12.1.2 Global Polyethersulfone Hemodialyzer Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Polyethersulfone Hemodialyzer Forecast by Type (2027-2032)
12.7 Global Polyethersulfone Hemodialyzer Forecast by Application (2027-2032)

13 KEY PLAYERS ANALYSIS

13.1 Nipro
  13.1.1 Nipro Company Information
  13.1.2 Nipro Polyethersulfone Hemodialyzer Product Portfolios and Specifications
  13.1.3 Nipro Polyethersulfone Hemodialyzer Sales, Revenue, Price and Gross Margin (2021-2026)
  13.1.4 Nipro Main Business Overview
  13.1.5 Nipro Latest Developments
13.2 JMS
  13.2.1 JMS Company Information
  13.2.2 JMS Polyethersulfone Hemodialyzer Product Portfolios and Specifications
  13.2.3 JMS Polyethersulfone Hemodialyzer Sales, Revenue, Price and Gross Margin (2021-2026)
  13.2.4 JMS Main Business Overview
  13.2.5 JMS Latest Developments
13.3 Farmasol
  13.3.1 Farmasol Company Information
  13.3.2 Farmasol Polyethersulfone Hemodialyzer Product Portfolios and Specifications
  13.3.3 Farmasol Polyethersulfone Hemodialyzer Sales, Revenue, Price and Gross Margin (2021-2026)
  13.3.4 Farmasol Main Business Overview
  13.3.5 Farmasol Latest Developments
13.4 Mozarc
  13.4.1 Mozarc Company Information
  13.4.2 Mozarc Polyethersulfone Hemodialyzer Product Portfolios and Specifications
  13.4.3 Mozarc Polyethersulfone Hemodialyzer Sales, Revenue, Price and Gross Margin (2021-2026)
  13.4.4 Mozarc Main Business Overview
  13.4.5 Mozarc Latest Developments
13.5 Bain Medical
  13.5.1 Bain Medical Company Information
  13.5.2 Bain Medical Polyethersulfone Hemodialyzer Product Portfolios and Specifications
  13.5.3 Bain Medical Polyethersulfone Hemodialyzer Sales, Revenue, Price and Gross Margin (2021-2026)
  13.5.4 Bain Medical Main Business Overview
  13.5.5 Bain Medical Latest Developments
13.6 Jiangxi Sanxin Medtec
  13.6.1 Jiangxi Sanxin Medtec Company Information
  13.6.2 Jiangxi Sanxin Medtec Polyethersulfone Hemodialyzer Product Portfolios and Specifications
  13.6.3 Jiangxi Sanxin Medtec Polyethersulfone Hemodialyzer Sales, Revenue, Price and Gross Margin (2021-2026)
  13.6.4 Jiangxi Sanxin Medtec Main Business Overview
  13.6.5 Jiangxi Sanxin Medtec Latest Developments
13.7 SWS Hemodialysis Care
  13.7.1 SWS Hemodialysis Care Company Information
  13.7.2 SWS Hemodialysis Care Polyethersulfone Hemodialyzer Product Portfolios and Specifications
  13.7.3 SWS Hemodialysis Care Polyethersulfone Hemodialyzer Sales, Revenue, Price and Gross Margin (2021-2026)
  13.7.4 SWS Hemodialysis Care Main Business Overview
  13.7.5 SWS Hemodialysis Care Latest Developments
13.8 Shanghai Peony Medical
  13.8.1 Shanghai Peony Medical Company Information
  13.8.2 Shanghai Peony Medical Polyethersulfone Hemodialyzer Product Portfolios and Specifications
  13.8.3 Shanghai Peony Medical Polyethersulfone Hemodialyzer Sales, Revenue, Price and Gross Margin (2021-2026)
  13.8.4 Shanghai Peony Medical Main Business Overview
  13.8.5 Shanghai Peony Medical Latest Developments
13.9 OCI Medical Device
  13.9.1 OCI Medical Device Company Information
  13.9.2 OCI Medical Device Polyethersulfone Hemodialyzer Product Portfolios and Specifications
  13.9.3 OCI Medical Device Polyethersulfone Hemodialyzer Sales, Revenue, Price and Gross Margin (2021-2026)
  13.9.4 OCI Medical Device Main Business Overview
  13.9.5 OCI Medical Device Latest Developments
13.10 Guangdong Baihe Medical
  13.10.1 Guangdong Baihe Medical Company Information
  13.10.2 Guangdong Baihe Medical Polyethersulfone Hemodialyzer Product Portfolios and Specifications
  13.10.3 Guangdong Baihe Medical Polyethersulfone Hemodialyzer Sales, Revenue, Price and Gross Margin (2021-2026)
  13.10.4 Guangdong Baihe Medical Main Business Overview
  13.10.5 Guangdong Baihe Medical Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES

Table 1. Polyethersulfone Hemodialyzer Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Polyethersulfone Hemodialyzer Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Low-Flux
Table 4. Major Players of High-Flux
Table 5. Global Polyethersulfone Hemodialyzer Sales by Type (2021-2026) & (K Units)
Table 6. Global Polyethersulfone Hemodialyzer Sales Market Share by Type (2021-2026)
Table 7. Global Polyethersulfone Hemodialyzer Revenue by Type (2021-2026) & ($ million)
Table 8. Global Polyethersulfone Hemodialyzer Revenue Market Share by Type (2021-2026)
Table 9. Global Polyethersulfone Hemodialyzer Sale Price by Type (2021-2026) & (US$/Unit)
Table 10. Major Players of Low-KUF Dialyzer
Table 11. Major Players of High-KUF Dialyzer
Table 12. Global Polyethersulfone Hemodialyzer Sales by Ultrafiltration Coefficient (2021-2026) & (K Units)
Table 13. Global Polyethersulfone Hemodialyzer Sales Market Share by Ultrafiltration Coefficient (2021-2026)
Table 14. Global Polyethersulfone Hemodialyzer Revenue by Ultrafiltration Coefficient (2021-2026) & ($ million)
Table 15. Global Polyethersulfone Hemodialyzer Revenue Market Share by Ultrafiltration Coefficient (2021-2026)
Table 16. Global Polyethersulfone Hemodialyzer Sale Price by Ultrafiltration Coefficient (2021-2026) & (US$/Unit)
Table 17. Major Players of Conventional PES Membrane Hemodialyzer
Table 18. Major Players of PES/PVP Modified Membrane Hemodialyzer
Table 19. Global Polyethersulfone Hemodialyzer Sales by Membrane Structure (2021-2026) & (K Units)
Table 20. Global Polyethersulfone Hemodialyzer Sales Market Share by Membrane Structure (2021-2026)
Table 21. Global Polyethersulfone Hemodialyzer Revenue by Membrane Structure (2021-2026) & ($ million)
Table 22. Global Polyethersulfone Hemodialyzer Revenue Market Share by Membrane Structure (2021-2026)
Table 23. Global Polyethersulfone Hemodialyzer Sale Price by Membrane Structure (2021-2026) & (US$/Unit)
Table 24. Global Polyethersulfone Hemodialyzer Sale by Application (2021-2026) & (K Units)
Table 25. Global Polyethersulfone Hemodialyzer Sale Market Share by Application (2021-2026)
Table 26. Global Polyethersulfone Hemodialyzer Revenue by Application (2021-2026) & ($ million)
Table 27. Global Polyethersulfone Hemodialyzer Revenue Market Share by Application (2021-2026)
Table 28. Global Polyethersulfone Hemodialyzer Sale Price by Application (2021-2026) & (US$/Unit)
Table 29. Global Polyethersulfone Hemodialyzer Sales by Company (2021-2026) & (K Units)
Table 30. Global Polyethersulfone Hemodialyzer Sales Market Share by Company (2021-2026)
Table 31. Global Polyethersulfone Hemodialyzer Revenue by Company (2021-2026) & ($ millions)
Table 32. Global Polyethersulfone Hemodialyzer Revenue Market Share by Company (2021-2026)
Table 33. Global Polyethersulfone Hemodialyzer Sale Price by Company (2021-2026) & (US$/Unit)
Table 34. Key Manufacturers Polyethersulfone Hemodialyzer Producing Area Distribution and Sales Area
Table 35. Players Polyethersulfone Hemodialyzer Products Offered
Table 36. Polyethersulfone Hemodialyzer Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 37. New Products and Potential Entrants
Table 38. Market M&A Activity & Strategy
Table 39. Global Polyethersulfone Hemodialyzer Sales by Geographic Region (2021-2026) & (K Units)
Table 40. Global Polyethersulfone Hemodialyzer Sales Market Share Geographic Region (2021-2026)
Table 41. Global Polyethersulfone Hemodialyzer Revenue by Geographic Region (2021-2026) & ($ millions)
Table 42. Global Polyethersulfone Hemodialyzer Revenue Market Share by Geographic Region (2021-2026)
Table 43. Global Polyethersulfone Hemodialyzer Sales by Country/Region (2021-2026) & (K Units)
Table 44. Global Polyethersulfone Hemodialyzer Sales Market Share by Country/Region (2021-2026)
Table 45. Global Polyethersulfone Hemodialyzer Revenue by Country/Region (2021-2026) & ($ millions)
Table 46. Global Polyethersulfone Hemodialyzer Revenue Market Share by Country/Region (2021-2026)
Table 47. Americas Polyethersulfone Hemodialyzer Sales by Country (2021-2026) & (K Units)
Table 48. Americas Polyethersulfone Hemodialyzer Sales Market Share by Country (2021-2026)
Table 49. Americas Polyethersulfone Hemodialyzer Revenue by Country (2021-2026) & ($ millions)
Table 50. Americas Polyethersulfone Hemodialyzer Sales by Type (2021-2026) & (K Units)
Table 51. Americas Polyethersulfone Hemodialyzer Sales by Application (2021-2026) & (K Units)
Table 52. APAC Polyethersulfone Hemodialyzer Sales by Region (2021-2026) & (K Units)
Table 53. APAC Polyethersulfone Hemodialyzer Sales Market Share by Region (2021-2026)
Table 54. APAC Polyethersulfone Hemodialyzer Revenue by Region (2021-2026) & ($ millions)
Table 55. APAC Polyethersulfone Hemodialyzer Sales by Type (2021-2026) & (K Units)
Table 56. APAC Polyethersulfone Hemodialyzer Sales by Application (2021-2026) & (K Units)
Table 57. Europe Polyethersulfone Hemodialyzer Sales by Country (2021-2026) & (K Units)
Table 58. Europe Polyethersulfone Hemodialyzer Revenue by Country (2021-2026) & ($ millions)
Table 59. Europe Polyethersulfone Hemodialyzer Sales by Type (2021-2026) & (K Units)
Table 60. Europe Polyethersulfone Hemodialyzer Sales by Application (2021-2026) & (K Units)
Table 61. Middle East & Africa Polyethersulfone Hemodialyzer Sales by Country (2021-2026) & (K Units)
Table 62. Middle East & Africa Polyethersulfone Hemodialyzer Revenue Market Share by Country (2021-2026)
Table 63. Middle East & Africa Polyethersulfone Hemodialyzer Sales by Type (2021-2026) & (K Units)
Table 64. Middle East & Africa Polyethersulfone Hemodialyzer Sales by Application (2021-2026) & (K Units)
Table 65. Key Market Drivers & Growth Opportunities of Polyethersulfone Hemodialyzer
Table 66. Key Market Challenges & Risks of Polyethersulfone Hemodialyzer
Table 67. Key Industry Trends of Polyethersulfone Hemodialyzer
Table 68. Polyethersulfone Hemodialyzer Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Polyethersulfone Hemodialyzer Distributors List
Table 71. Polyethersulfone Hemodialyzer Customer List
Table 72. Global Polyethersulfone Hemodialyzer Sales Forecast by Region (2027-2032) & (K Units)
Table 73. Global Polyethersulfone Hemodialyzer Revenue Forecast by Region (2027-2032) & ($ millions)
Table 74. Americas Polyethersulfone Hemodialyzer Sales Forecast by Country (2027-2032) & (K Units)
Table 75. Americas Polyethersulfone Hemodialyzer Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 76. APAC Polyethersulfone Hemodialyzer Sales Forecast by Region (2027-2032) & (K Units)
Table 77. APAC Polyethersulfone Hemodialyzer Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 78. Europe Polyethersulfone Hemodialyzer Sales Forecast by Country (2027-2032) & (K Units)
Table 79. Europe Polyethersulfone Hemodialyzer Revenue Forecast by Country (2027-2032) & ($ millions)
Table 80. Middle East & Africa Polyethersulfone Hemodialyzer Sales Forecast by Country (2027-2032) & (K Units)
Table 81. Middle East & Africa Polyethersulfone Hemodialyzer Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. Global Polyethersulfone Hemodialyzer Sales Forecast by Type (2027-2032) & (K Units)
Table 83. Global Polyethersulfone Hemodialyzer Revenue Forecast by Type (2027-2032) & ($ millions)
Table 84. Global Polyethersulfone Hemodialyzer Sales Forecast by Application (2027-2032) & (K Units)
Table 85. Global Polyethersulfone Hemodialyzer Revenue Forecast by Application (2027-2032) & ($ millions)
Table 86. Nipro Basic Information, Polyethersulfone Hemodialyzer Manufacturing Base, Sales Area and Its Competitors
Table 87. Nipro Polyethersulfone Hemodialyzer Product Portfolios and Specifications
Table 88. Nipro Polyethersulfone Hemodialyzer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 89. Nipro Main Business
Table 90. Nipro Latest Developments
Table 91. JMS Basic Information, Polyethersulfone Hemodialyzer Manufacturing Base, Sales Area and Its Competitors
Table 92. JMS Polyethersulfone Hemodialyzer Product Portfolios and Specifications
Table 93. JMS Polyethersulfone Hemodialyzer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 94. JMS Main Business
Table 95. JMS Latest Developments
Table 96. Farmasol Basic Information, Polyethersulfone Hemodialyzer Manufacturing Base, Sales Area and Its Competitors
Table 97. Farmasol Polyethersulfone Hemodialyzer Product Portfolios and Specifications
Table 98. Farmasol Polyethersulfone Hemodialyzer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 99. Farmasol Main Business
Table 100. Farmasol Latest Developments
Table 101. Mozarc Basic Information, Polyethersulfone Hemodialyzer Manufacturing Base, Sales Area and Its Competitors
Table 102. Mozarc Polyethersulfone Hemodialyzer Product Portfolios and Specifications
Table 103. Mozarc Polyethersulfone Hemodialyzer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 104. Mozarc Main Business
Table 105. Mozarc Latest Developments
Table 106. Bain Medical Basic Information, Polyethersulfone Hemodialyzer Manufacturing Base, Sales Area and Its Competitors
Table 107. Bain Medical Polyethersulfone Hemodialyzer Product Portfolios and Specifications
Table 108. Bain Medical Polyethersulfone Hemodialyzer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 109. Bain Medical Main Business
Table 110. Bain Medical Latest Developments
Table 111. Jiangxi Sanxin Medtec Basic Information, Polyethersulfone Hemodialyzer Manufacturing Base, Sales Area and Its Competitors
Table 112. Jiangxi Sanxin Medtec Polyethersulfone Hemodialyzer Product Portfolios and Specifications
Table 113. Jiangxi Sanxin Medtec Polyethersulfone Hemodialyzer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 114. Jiangxi Sanxin Medtec Main Business
Table 115. Jiangxi Sanxin Medtec Latest Developments
Table 116. SWS Hemodialysis Care Basic Information, Polyethersulfone Hemodialyzer Manufacturing Base, Sales Area and Its Competitors
Table 117. SWS Hemodialysis Care Polyethersulfone Hemodialyzer Product Portfolios and Specifications
Table 118. SWS Hemodialysis Care Polyethersulfone Hemodialyzer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 119. SWS Hemodialysis Care Main Business
Table 120. SWS Hemodialysis Care Latest Developments
Table 121. Shanghai Peony Medical Basic Information, Polyethersulfone Hemodialyzer Manufacturing Base, Sales Area and Its Competitors
Table 122. Shanghai Peony Medical Polyethersulfone Hemodialyzer Product Portfolios and Specifications
Table 123. Shanghai Peony Medical Polyethersulfone Hemodialyzer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 124. Shanghai Peony Medical Main Business
Table 125. Shanghai Peony Medical Latest Developments
Table 126. OCI Medical Device Basic Information, Polyethersulfone Hemodialyzer Manufacturing Base, Sales Area and Its Competitors
Table 127. OCI Medical Device Polyethersulfone Hemodialyzer Product Portfolios and Specifications
Table 128. OCI Medical Device Polyethersulfone Hemodialyzer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 129. OCI Medical Device Main Business
Table 130. OCI Medical Device Latest Developments
Table 131. Guangdong Baihe Medical Basic Information, Polyethersulfone Hemodialyzer Manufacturing Base, Sales Area and Its Competitors
Table 132. Guangdong Baihe Medical Polyethersulfone Hemodialyzer Product Portfolios and Specifications
Table 133. Guangdong Baihe Medical Polyethersulfone Hemodialyzer Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 134. Guangdong Baihe Medical Main Business
Table 135. Guangdong Baihe Medical Latest Developments

LIST OF FIGURES

Figure 1. Picture of Polyethersulfone Hemodialyzer
Figure 2. Polyethersulfone Hemodialyzer Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Polyethersulfone Hemodialyzer Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Polyethersulfone Hemodialyzer Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Polyethersulfone Hemodialyzer Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Polyethersulfone Hemodialyzer Sales Market Share by Country/Region (2025)
Figure 10. Polyethersulfone Hemodialyzer Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Low-Flux
Figure 12. Product Picture of High-Flux
Figure 13. Global Polyethersulfone Hemodialyzer Sales Market Share by Type in 2026
Figure 14. Global Polyethersulfone Hemodialyzer Revenue Market Share by Type (2021-2026)
Figure 15. Product Picture of Low-KUF Dialyzer
Figure 16. Product Picture of High-KUF Dialyzer
Figure 17. Global Polyethersulfone Hemodialyzer Sales Market Share by Ultrafiltration Coefficient in 2026
Figure 18. Global Polyethersulfone Hemodialyzer Revenue Market Share by Ultrafiltration Coefficient (2021-2026)
Figure 19. Product Picture of Conventional PES Membrane Hemodialyzer
Figure 20. Product Picture of PES/PVP Modified Membrane Hemodialyzer
Figure 21. Global Polyethersulfone Hemodialyzer Sales Market Share by Membrane Structure in 2026
Figure 22. Global Polyethersulfone Hemodialyzer Revenue Market Share by Membrane Structure (2021-2026)
Figure 23. Polyethersulfone Hemodialyzer Consumed in Hospital
Figure 24. Global Polyethersulfone Hemodialyzer Market: Hospital (2021-2026) & (K Units)
Figure 25. Polyethersulfone Hemodialyzer Consumed in Dialysis Center
Figure 26. Global Polyethersulfone Hemodialyzer Market: Dialysis Center (2021-2026) & (K Units)
Figure 27. Polyethersulfone Hemodialyzer Consumed in Other
Figure 28. Global Polyethersulfone Hemodialyzer Market: Other (2021-2026) & (K Units)
Figure 29. Global Polyethersulfone Hemodialyzer Sale Market Share by Application (2025)
Figure 30. Global Polyethersulfone Hemodialyzer Revenue Market Share by Application in 2025
Figure 31. Polyethersulfone Hemodialyzer Sales by Company in 2025 (K Units)
Figure 32. Global Polyethersulfone Hemodialyzer Sales Market Share by Company in 2025
Figure 33. Polyethersulfone Hemodialyzer Revenue by Company in 2025 ($ millions)
Figure 34. Global Polyethersulfone Hemodialyzer Revenue Market Share by Company in 2025
Figure 35. Global Polyethersulfone Hemodialyzer Sales Market Share by Geographic Region (2021-2026)
Figure 36. Global Polyethersulfone Hemodialyzer Revenue Market Share by Geographic Region in 2025
Figure 37. Americas Polyethersulfone Hemodialyzer Sales 2021-2026 (K Units)
Figure 38. Americas Polyethersulfone Hemodialyzer Revenue 2021-2026 ($ millions)
Figure 39. APAC Polyethersulfone Hemodialyzer Sales 2021-2026 (K Units)
Figure 40. APAC Polyethersulfone Hemodialyzer Revenue 2021-2026 ($ millions)
Figure 41. Europe Polyethersulfone Hemodialyzer Sales 2021-2026 (K Units)
Figure 42. Europe Polyethersulfone Hemodialyzer Revenue 2021-2026 ($ millions)
Figure 43. Middle East & Africa Polyethersulfone Hemodialyzer Sales 2021-2026 (K Units)
Figure 44. Middle East & Africa Polyethersulfone Hemodialyzer Revenue 2021-2026 ($ millions)
Figure 45. Americas Polyethersulfone Hemodialyzer Sales Market Share by Country in 2025
Figure 46. Americas Polyethersulfone Hemodialyzer Revenue Market Share by Country (2021-2026)
Figure 47. Americas Polyethersulfone Hemodialyzer Sales Market Share by Type (2021-2026)
Figure 48. Americas Polyethersulfone Hemodialyzer Sales Market Share by Application (2021-2026)
Figure 49. United States Polyethersulfone Hemodialyzer Revenue Growth 2021-2026 ($ millions)
Figure 50. Canada Polyethersulfone Hemodialyzer Revenue Growth 2021-2026 ($ millions)
Figure 51. Mexico Polyethersulfone Hemodialyzer Revenue Growth 2021-2026 ($ millions)
Figure 52. Brazil Polyethersulfone Hemodialyzer Revenue Growth 2021-2026 ($ millions)
Figure 53. APAC Polyethersulfone Hemodialyzer Sales Market Share by Region in 2025
Figure 54. APAC Polyethersulfone Hemodialyzer Revenue Market Share by Region (2021-2026)
Figure 55. APAC Polyethersulfone Hemodialyzer Sales Market Share by Type (2021-2026)
Figure 56. APAC Polyethersulfone Hemodialyzer Sales Market Share by Application (2021-2026)
Figure 57. China Polyethersulfone Hemodialyzer Revenue Growth 2021-2026 ($ millions)
Figure 58. Japan Polyethersulfone Hemodialyzer Revenue Growth 2021-2026 ($ millions)
Figure 59. South Korea Polyethersulfone Hemodialyzer Revenue Growth 2021-2026 ($ millions)
Figure 60. Southeast Asia Polyethersulfone Hemodialyzer Revenue Growth 2021-2026 ($ millions)
Figure 61. India Polyethersulfone Hemodialyzer Revenue Growth 2021-2026 ($ millions)
Figure 62. Australia Polyethersulfone Hemodialyzer Revenue Growth 2021-2026 ($ millions)
Figure 63. China Taiwan Polyethersulfone Hemodialyzer Revenue Growth 2021-2026 ($ millions)
Figure 64. Europe Polyethersulfone Hemodialyzer Sales Market Share by Country in 2025
Figure 65. Europe Polyethersulfone Hemodialyzer Revenue Market Share by Country (2021-2026)
Figure 66. Europe Polyethersulfone Hemodialyzer Sales Market Share by Type (2021-2026)
Figure 67. Europe Polyethersulfone Hemodialyzer Sales Market Share by Application (2021-2026)
Figure 68. Germany Polyethersulfone Hemodialyzer Revenue Growth 2021-2026 ($ millions)
Figure 69. France Polyethersulfone Hemodialyzer Revenue Growth 2021-2026 ($ millions)
Figure 70. UK Polyethersulfone Hemodialyzer Revenue Growth 2021-2026 ($ millions)
Figure 71. Italy Polyethersulfone Hemodialyzer Revenue Growth 2021-2026 ($ millions)
Figure 72. Russia Polyethersulfone Hemodialyzer Revenue Growth 2021-2026 ($ millions)
Figure 73. Middle East & Africa Polyethersulfone Hemodialyzer Sales Market Share by Country (2021-2026)
Figure 74. Middle East & Africa Polyethersulfone Hemodialyzer Sales Market Share by Type (2021-2026)
Figure 75. Middle East & Africa Polyethersulfone Hemodialyzer Sales Market Share by Application (2021-2026)
Figure 76. Egypt Polyethersulfone Hemodialyzer Revenue Growth 2021-2026 ($ millions)
Figure 77. South Africa Polyethersulfone Hemodialyzer Revenue Growth 2021-2026 ($ millions)
Figure 78. Israel Polyethersulfone Hemodialyzer Revenue Growth 2021-2026 ($ millions)
Figure 79. Turkey Polyethersulfone Hemodialyzer Revenue Growth 2021-2026 ($ millions)
Figure 80. GCC Countries Polyethersulfone Hemodialyzer Revenue Growth 2021-2026 ($ millions)
Figure 81. Manufacturing Cost Structure Analysis of Polyethersulfone Hemodialyzer in 2026
Figure 82. Manufacturing Process Analysis of Polyethersulfone Hemodialyzer
Figure 83. Industry Chain Structure of Polyethersulfone Hemodialyzer
Figure 84. Channels of Distribution
Figure 85. Global Polyethersulfone Hemodialyzer Sales Market Forecast by Region (2027-2032)
Figure 86. Global Polyethersulfone Hemodialyzer Revenue Market Share Forecast by Region (2027-2032)
Figure 87. Global Polyethersulfone Hemodialyzer Sales Market Share Forecast by Type (2027-2032)
Figure 88. Global Polyethersulfone Hemodialyzer Revenue Market Share Forecast by Type (2027-2032)
Figure 89. Global Polyethersulfone Hemodialyzer Sales Market Share Forecast by Application (2027-2032)
Figure 90. Global Polyethersulfone Hemodialyzer Revenue Market Share Forecast by Application (2027-2032)